Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-16-061295

Senior VP - Drug Discovery sold 30,000 shares at $4.06 ($121,800)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-08-25 Sale : show line 1 in the form −30,000 $4.06 $121,800 111,428 D
Open-market sales · 30,000 sh · avg $4.06 · $121,800
Loading xslF345X03/form4.xml…